Functional genomics of AP-2α and AP-2γ in cancers: in silico study.

BMC Medical Genomics
Damian KołatElżbieta Płuciennik

Abstract

Among all causes of death, cancer is the most prevalent and is only outpaced by cardiovascular diseases. Molecular theory of carcinogenesis states that apoptosis and proliferation are regulated by groups of tumor suppressors or oncogenes. Transcription factors are example of proteins comprising representatives of both cancer-related groups. Exemplary family of transcription factors which exhibits dualism of function is Activating enhancer-binding Protein 2 (AP-2). Scientific reports concerning their function in carcinogenesis depend on particular family member and/or tumor type which proves the issue to be unsolved. Therefore, the present study examines role of the best-described AP-2 representatives, AP-2α and AP-2γ, through ontological analysis of their target genes and investigation what processes are differentially regulated in 21 cancers using samples deposited in Genomic Data Analysis Center (GDAC) Firehose. Expression data with clinical annotation was collected from TCGA-dedicated repository GDAC Firehose. Transcription factor targets were obtained from Gene Transcription Regulation Database (GTRD), TRANScription FACtor database (TRANSFAC) and Transcriptional Regulatory Relationships Unraveled by Sentence-based Text mini...Continue Reading

References

Jun 23, 2000·British Journal of Cancer·M A AnttilaV M Kosma
Jan 20, 2006·Genome Biology·Dawid EckertHubert Schorle
Jul 27, 2006·Neoplasia : an International Journal for Oncology Research·Hualei LiFrederick E Domann
Oct 9, 2012·Seminars in Oncology·Anirban P MitraRichard J Cote
Mar 8, 2014·PLoS Computational Biology·Alexandra Jilkine, Ryan N Gutenkunst
Mar 22, 2014·Cancer Cell·Patricia A J Muller, Karen H Vousden
Apr 1, 2014·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Roman Paduch
Jul 30, 2014·Apoptosis : an International Journal on Programmed Cell Death·Anne BenardPeter J K Kuppen
Jan 28, 2015·Epigenetics : Official Journal of the DNA Methylation Society·Andrea R HallbergFrederick E Domann
Jul 15, 2015·Breast Cancer Research and Treatment·Susan M PerkinsHarikrishna Nakshatri
Aug 25, 2015·Anti-cancer Agents in Medicinal Chemistry·Abdulrazzaq Neamah ZghairAnil K Sharma
Mar 8, 2016·Cell Reports·Fengju ChenChad J Creighton
Apr 14, 2016·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Iain Joseph Hyndman
Aug 9, 2016·Progress in Biophysics and Molecular Biology·Carlos Sonnenschein, Ana M Soto
Dec 8, 2016·Nucleic Acids Research·Ivan YevshinFedor Kolpakov
Apr 26, 2017·Apoptosis : an International Journal on Programmed Cell Death·Wei LianWensheng Chen
Apr 30, 2017·Journal of Thoracic Disease·Hiroki Nagai, Young Hak Kim
Feb 15, 2018·Journal of Experimental & Clinical Cancer Research : CR·Xu WangLei Wang
Jul 5, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Zhenglin LiWuguo Deng
Aug 28, 2018·Cancer Management and Research·Hong Rong Wu, Jian Zhang
Nov 18, 2018·Nucleic Acids Research·Ivan YevshinFedor Kolpakov

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
RNA-seq
PCA

Software Mentioned

Assembler
Monocle3 R package
pheatmap
TCGA
Protein Analysis Through Evolutionary Relationships ( PANTHER )
Monocle3

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis